ELISA was performed in different groups of individuals. Groups negative for VL (white circle): control group (CT, n = 70), Chagas’ disease (CD, n = 68). Groups positive for VL (black circle): visceral leishmaniasis (VL, n = 70). The anti-peptides 1–6, Mix I, II, III, IV and SLiA reactivity between groups were compared by Kruskal-Wallis followed by Dunn’s post-test for multi-group comparisons. The differences were considered statistically significant at ***p<0.001, highlighted by connecting lines. Cut-offs were determined by ROC curves.</p
<p>Comparison of the sensitivity/specificity of the new VL protein capture ELISA (this study) with t...
<p>Immunoreactivity against the 12 selected peptides was determined in a set of 21 <i>O</i>. <i>volv...
<p>(A) Reactivity of DBL4ε anti<b>-</b>sera to each peptide is shown as the average O.D. values for ...
<p><b>TL and VL:</b> An ELISA was performed in different groups of individuals (CT, control group, n...
<p><b>TL and VL</b>: ELISAs were performed on samples from different groups of individuals (CT, cont...
<p>ODs for 106 VL sera diluted 1∶800 were measured in the rKLO8 ELISA and compared with DAT antibody...
<p>Pools of sera (n = 10) from the different groups were depleted with peptide-1 (CT, control group;...
Two ELISA assays were performed using human sera from the following groups: NC, negative control, n ...
(A and B) ELISA reactivity against select antigens for sera (T0 and T3) of patients classified as re...
<p>The rKLO8 or rK39 proteins were used and compared in ELISA using protein concentrations of 5 ng/1...
<p>Detection of anti-leishmania total IgG antibodies with synthetic peptides by ELISA assay using se...
<p>The pool of sera (n = 10) were depleted with peptide-1 (TPGKPTLDT), peptide-2 (VRDPAPQFS) and unr...
<p>Protein concentrations of 5ng/100μl rKLO8 or rK39 were tested with sera of patients and controls ...
<p>Detection of anti-leishmania total IgG antibodies with synthetic peptides by ELISA assay using se...
<p>p-ELISA = enzyme immunoassay with antigens of promastigotes of <i>Leishmania</i> sp. DAT = direct...
<p>Comparison of the sensitivity/specificity of the new VL protein capture ELISA (this study) with t...
<p>Immunoreactivity against the 12 selected peptides was determined in a set of 21 <i>O</i>. <i>volv...
<p>(A) Reactivity of DBL4ε anti<b>-</b>sera to each peptide is shown as the average O.D. values for ...
<p><b>TL and VL:</b> An ELISA was performed in different groups of individuals (CT, control group, n...
<p><b>TL and VL</b>: ELISAs were performed on samples from different groups of individuals (CT, cont...
<p>ODs for 106 VL sera diluted 1∶800 were measured in the rKLO8 ELISA and compared with DAT antibody...
<p>Pools of sera (n = 10) from the different groups were depleted with peptide-1 (CT, control group;...
Two ELISA assays were performed using human sera from the following groups: NC, negative control, n ...
(A and B) ELISA reactivity against select antigens for sera (T0 and T3) of patients classified as re...
<p>The rKLO8 or rK39 proteins were used and compared in ELISA using protein concentrations of 5 ng/1...
<p>Detection of anti-leishmania total IgG antibodies with synthetic peptides by ELISA assay using se...
<p>The pool of sera (n = 10) were depleted with peptide-1 (TPGKPTLDT), peptide-2 (VRDPAPQFS) and unr...
<p>Protein concentrations of 5ng/100μl rKLO8 or rK39 were tested with sera of patients and controls ...
<p>Detection of anti-leishmania total IgG antibodies with synthetic peptides by ELISA assay using se...
<p>p-ELISA = enzyme immunoassay with antigens of promastigotes of <i>Leishmania</i> sp. DAT = direct...
<p>Comparison of the sensitivity/specificity of the new VL protein capture ELISA (this study) with t...
<p>Immunoreactivity against the 12 selected peptides was determined in a set of 21 <i>O</i>. <i>volv...
<p>(A) Reactivity of DBL4ε anti<b>-</b>sera to each peptide is shown as the average O.D. values for ...